https://www.cegat.de/web/wp-content/uploads/2019/07/admin-ajax2.jpg225400Alexander Borsthttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngAlexander Borst2019-08-13 09:36:082019-08-13 09:36:08PEDIA: prioritization of exome data by image analysis.
https://www.cegat.de/web/wp-content/uploads/2019/07/admin-ajax2.jpg225400Alexander Borsthttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngAlexander Borst2019-08-13 08:47:272019-08-13 08:47:27De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy.
https://www.cegat.de/web/wp-content/uploads/2018/12/Publikations-Keyvisual-V3.jpg10801920Nora Zellerhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngNora Zeller2019-08-01 12:25:312019-08-01 12:25:31Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism.
https://www.cegat.de/web/wp-content/uploads/2018/03/Publikation-Keyvisual-V2-blank-WEB.jpg5791030Andreas Ritterhttps://www.cegat.de/web/wp-content/uploads/2017/11/CeGaT_Logo_Neu_horizontal_mit-claim-300x77.pngAndreas Ritter2019-07-15 09:01:482019-08-01 08:38:06Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study.
